Abstract
Daratumumab Versus Lenalidomide Maintenance Therapy for Multiple Myeloma: A Randomized Pilot Study Comparing Patient-Reported Health Related Quality of Life Measures
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have